Reiner A, Dragatsis I, Dietrich P. Genetics and neuropathology of Huntington’s disease. Int Rev Neurobiol. 2011;98:325–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell. 1993;72(6):971–83.

Warby SC, Montpetit A, Hayden AR, Carroll JB, Butland SL, Visscher H, et al. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet. 2009;84(3):351–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tabrizi SJ, Flower MD, Ross CA, Wild EJ. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol. 2020;16(10):529–46.

Article  PubMed  Google Scholar 

Hazeki N, Nakamura K, Goto J, Kanazawa I. Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract. Biochem Biophys Res Commun. 1999;256(2):361–6.

Article  CAS  PubMed  Google Scholar 

Wang CE, Tydlacka S, Orr AL, Yang SH, Graham RK, Hayden MR, et al. Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington’s disease. Hum Mol Genet. 2008;17(17):2738–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Juenemann K, Schipper-Krom S, Wiemhoefer A, Kloss A, Sanz Sanz A, Reits EAJ. Expanded polyglutamine-containing N-terminal huntingtin fragments are entirely degraded by mammalian proteasomes. J Biol Chem. 2013;288(38):27068–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strong TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, Swaroop M, et al. Widespread expression of the human and rat Huntington’s disease gene in brain and nonneural tissues. Nat Genet. 1993;5(3):259–65.

Article  CAS  PubMed  Google Scholar 

Li SH, Schilling G, Young WS 3rd, Li XJ, Margolis RL, Stine OC, et al. Huntington’s disease gene (IT15) is widely expressed in human and rat tissues. Neuron. 1993;11(5):985–93.

Article  CAS  PubMed  Google Scholar 

Landwehrmeyer GB, McNeil SM, Dure LST, Ge P, Aizawa H, Huang Q, et al. Huntington’s disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol. 1995;37(2):218–30.

Article  CAS  PubMed  Google Scholar 

Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol. 2005;171(6):1001–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crotti A, Benner C, Kerman BE, Gosselin D, Lagier-Tourenne C, Zuccato C, et al. Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat Neurosci. 2014;17(4):513–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferrari Bardile C, Garcia-Miralles M, Caron NS, Rayan NA, Langley SR, Harmston N, et al. Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease. Proc Natl Acad Sci U S A. 2019;116(19):9622–7.

Article  PubMed  PubMed Central  Google Scholar 

Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, et al. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington’s disease subjects. Hum Mol Genet. 2010;19(15):3053–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18(4):225–42.

Article  CAS  PubMed  Google Scholar 

Sierra A, Paolicelli RC, Kettenmann H. Cien anos de microglia: milestones in a century of microglial research. Trends Neurosci. 2019;42(11):778–92.

Article  CAS  PubMed  Google Scholar 

Thion MS, Garel S. Microglial ontogeny, diversity and neurodevelopmental functions. Curr Opin Genet Dev. 2020;65:186–94.

Article  CAS  PubMed  Google Scholar 

Davis EJ, Foster TD, Thomas WE. Cellular forms and functions of brain microglia. Brain Res Bull. 1994;34(1):73–8.

Article  CAS  PubMed  Google Scholar 

Tian L, Ma L, Kaarela T, Li Z. Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases. J Neuroinflamm. 2012;9:155.

Article  CAS  Google Scholar 

Streit WJ. Microglial response to brain injury: a brief synopsis. Toxicol Pathol. 2000;28(1):28–30.

Article  CAS  PubMed  Google Scholar 

Lively S, Schlichter LC. Microglia responses to pro-inflammatory stimuli (LPS, IFNgamma+TNFalpha) and reprogramming by resolving cytokines (IL-4, IL-10). Front Cell Neurosci. 2018;12:215.

Article  PubMed  PubMed Central  Google Scholar 

Lucin KM, Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron. 2009;64(1):110–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463–77.

Article  CAS  PubMed  Google Scholar 

Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353(6301):777–83.

Article  CAS  PubMed  Google Scholar 

Politis M, Lahiri N, Niccolini F, Su P, Wu K, Giannetti P, et al. Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington’s disease gene carriers. Neurobiol Dis. 2015;83:115–21.

Article  CAS  PubMed  Google Scholar 

Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P. Imaging microglial activation in Huntington’s disease. Brain Res Bull. 2007;72(2–3):148–51.

Article  CAS  PubMed  Google Scholar 

Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P. Microglial activation in presymptomatic Huntington’s disease gene carriers. Brain. 2007;130(Pt 7):1759–66.

Article  PubMed  Google Scholar 

Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, et al. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology. 2006;66(11):1638–43.

Article  CAS  PubMed  Google Scholar 

Bragg RM, Coffey SR, Weston RM, Ament SA, Cantle JP, Minnig S, et al. Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt(Q111/+) model of Huntington’s disease. Sci Rep. 2017;7:41570.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coffey SR, Bragg RM, Minnig S, Ament SA, Cantle JP, Glickenhaus A, et al. Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6HttQ111/+ mouse model of Huntington’s disease. PLoS ONE. 2017;12(4): e0175968.

Article  PubMed  PubMed Central  Google Scholar 

Johnson E, Chase K, McGowan S, Mondo E, Pfister E, Mick E, et al. Safety of striatal infusion of siRNA in a transgenic Huntington’s disease mouse model. J Huntington’s Dis. 2015;4(3):219–29.

Article  CAS  Google Scholar 

Franciosi S, Ryu JK, Shim Y, Hill A, Connolly C, Hayden MR, et al. Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease. Neurobiol Dis. 2012;45(1):438–49.

Article  CAS  PubMed  Google Scholar 

Godavarthi SK, Narender D, Mishra A, Goswami A, Rao SN, Nukina N, Jana NR. Induction of chemokines, MCP-1, and KC in the mutant huntingtin expressing neuronal cells because of proteasomal dysfunction. J Neurochem. 2009;108(3):787–95.

Article  CAS  PubMed  Google Scholar 

Ma L, Morton AJ, Nicholson LF. Microglia density decreases with age in a mouse model of Huntington’s disease. Glia. 2003;43(3):274–80.

Article  PubMed  Google Scholar 

Zwilling D, Huang SY, Sathyasaikumar KV, Notarangelo FM, Guidetti P, Wu HQ, et al. Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell. 2011;145(6):863–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alpaugh M, Galleguillos D, Forero J, Morales LC, Lackey SW, Kar P, et al. Disease-modifying effects of ganglioside GM1 in Huntington’s disease models. EMBO Mol Med. 2017;9(11):1537–57.

Article  CAS